Plus Therapeutics SG&A Expense (Annual) Trends

Plus Therapeutics Inc (PSTV)

1.30 0.00 (0.00%) USD | NASDAQ | Oct 04, 16:00

1.32 +0.02 (+1.54%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1998. Upgrade now.

Date	Value
December 31, 2023	8.544M
December 31, 2022	10.24M
December 31, 2021	6.853M
December 31, 2020	6.406M
December 31, 2019	5.29M
December 31, 2018	6.222M
December 31, 2017	11.19M
December 31, 2016	12.17M
December 31, 2015	12.43M
December 31, 2014	22.36M
December 31, 2013	25.06M
December 31, 2012	25.16M
December 31, 2011	28.29M

Date	Value
December 31, 2010	23.61M
December 31, 2009	17.00M
December 31, 2008	16.33M
December 31, 2007	16.86M
December 31, 2006	14.60M
December 31, 2005	11.76M
December 31, 2004	8.964M
December 31, 2003	8.998M
December 31, 2002	7.939M
December 31, 2001	8.071M
December 31, 2000	5.184M
December 31, 1999	3.669M
December 31, 1998	0.806M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

5.29M

Minimum

2019

10.24M

Maximum

2022

7.466M

Average

6.853M

Median

2021

SG&A Expense (Annual) Benchmarks